Clinical Trials Logo

Filter by:
NCT ID: NCT01168180 Completed - Clinical trials for Scapulocostal Syndrome

Traditional Thai Massage and Scapulocostal Syndrome

Start date: July 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy of traditional Thai massage on pain intensity, pressure pain threshold, muscle tension, anxiety, cervical range of motion, patient satisfaction and side effects in the treatment of scapulocostal syndrome.

NCT ID: NCT01167881 Completed - Clinical trials for Diabetes Mellitus, Type 2

Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes

Start date: August 2010
Phase: Phase 3
Study type: Interventional

This is a pivotal phase III study, mandatory to seek approval by regulatory authorities for BI 10773 as an anti-diabetic agent compared to an active comparator in patients with type 2 diabetes mellitus and insufficient glycaemic control.

NCT ID: NCT01167062 Recruiting - Ureteral Calculi Clinical Trials

Efficacy of Tamsulosin Oral-controlled Absorption System (OCAS) in the Treatment of Distal Ureteral Stones

Start date: June 2010
Phase: Phase 4
Study type: Interventional

This is a randomized double blind placebo-controlled study that will assess the efficacy of Tamsulosin oral-controlled absorption system (OCAS) 0.4 mg in the conjunctive medical treatment of distal ureteral stones with a size of 4-10 mm compared to placebo in control group.

NCT ID: NCT01164293 Completed - Food Allergy Clinical Trials

Atopy Patch Test in Children With Food Allergy-related Gastrointestinal Symptoms

APT
Start date: April 2010
Phase: Phase 1
Study type: Interventional

Positive reactions in Atopy patch test in children with food allergy-related gastrointestinal symptoms

NCT ID: NCT01163240 Completed - Hepatitis B Clinical Trials

Epidemiological Study in Children and Adolescents With Chronic Hepatitis B

EPIC B
Start date: June 2009
Phase: N/A
Study type: Observational

The purpose of this study is to collect epidemiological data in children and adolescents with chronic hepatitis B(CHB), in particular data on the prevalence of HBeAg positive disease with associated ALT levels , active HBeAg negative disease and decompensated CHB in the pediatric population. Family history and history of HBV transmission is essential to assess the course of the disease and can be used to determine the best mode of treatment This information will be used to assist with the feasibility and design of studies for the Novartis clinical pediatric development program, as the current epidemiology of ediatric CHB is not accurately known in Western countries or the rest of the world making pediatric studies difficult to plan and conduct. This study forms part of the Novartis Pediatric Investigational Plan, a post marketing approval commitment to the EMEA Pediatric Committee.

NCT ID: NCT01161524 Completed - Epilepsy Clinical Trials

A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents

Start date: September 2010
Phase: Phase 2
Study type: Interventional

This study is designed to investigate the short- and long-term effects of perampanel on cognition, growth, and development in adolescents.

NCT ID: NCT01161160 Completed - Influenza Clinical Trials

Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old

Start date: July 1, 2010
Phase: Phase 2
Study type: Interventional

This study is designed to characterize the safety and immunogenicity of pandemic influenza (H1N1) candidate vaccines GSK2340274A and GSK234072A in children 3 to less than 10 years old.

NCT ID: NCT01160120 Completed - HIV Clinical Trials

Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz

Start date: June 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the mid levels of the tenofovir, lamivudine, and efavirenz, and 144 weeks safety and efficacy of the generic fixed dose combination of tenofovir /lamivudine/efavirenz tablets 300/300/600 mg in Thai HIV-infected patients.

NCT ID: NCT01159275 Completed - HIV-1 Infections Clinical Trials

Lopinavir (LPV) Dose Reduction

Start date: July 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to study the pharmacokinetics profiles of generic lopinavir/ritonavir and Pediatric Aluvia® at reduced dose by assessing safety, tolerability and efficacy.

NCT ID: NCT01159223 Completed - HIV Infections Clinical Trials

Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA)

Start date: May 2011
Phase: Phase 4
Study type: Interventional

This study will compare the efficacy and safety of ATV/r at either 200/100 mg or 300/100mg given daily in Thai patients in combination with 2NRTIs.